ZSSYe001-A

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

iPSC Line
hPSCreg name	ZSSYe001-A
Cite as:	ZSSYe001-A (RRID:CVCL_YP14)
iPSC line type	Human embryonic stem cell (hESC)
Similar iPSC lines	No similar lines found.
Last update	2nd March 2021
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Third Affiliated Hospital of Sun Yat-sen University (ZSSY) Contact: Third Affiliated Hospital of Sun Yat-sen University (ZSSY)
Owner	Third Affiliated Hospital of Sun Yat-sen University (ZSSY)
Distributors	Third Affiliated Hospital of Sun Yat-sen University (ZSSY)
External iPSC Databases
Cellosaurus	CVCL_YP14
BioSamples	SAMEA8325241
Wikidata	Q98136625
General iPSC Information
Publications	Xu C et al. Generation of a DAPK1 knockout first (conditional ready) human embryonic stem cell line (ZSSYe001-A) by CRISPR-Cas9 technology. Stem cell research. 2020 Mar;43:101693. Zhang B. CRISPR/Cas gene therapy. Journal of cellular physiology. 2021 Apr;236(4):2459-2481. Yang Xianguang et al. A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment. Functional & Integrative Genomics. 2023-06-00. Raffaele Ivana et al. CRISPR/Cas9 and iPSC-Based Therapeutic Approaches in Alzheimer’s Disease. Antioxidants. 2025-06-25. Zhang Xiuli et al. Death-associated protein kinase 1: a double-edged sword in health and disease. Frontiers in Immunology. 2025-08-21.
* Is the cell line readily obtainable for third parties?	Yes Research use: allowed Clinical use: not allowed Commercial use: not allowed